Subcortical atrophy and cognition

Objectives: Gray matter (GM) atrophy is common in multiple sclerosis (MS), as is cognitive dysfunction. Understanding the exact relationship between atrophy and cognition requires further investigation. The aim of this study was to investigate the relationship between subcortical GM atrophy and cognition in early relapsing onset MS. Methods: Structural MRI and neuropsychological evaluations were performed in 120 patients (80 women) and 50 controls (30 women), part of an early inception cohort, 6 years postdiagnosis. Deep GM volumes were segmented automatically. Cognition was assessed in 7 domains. Stepwise linear regression was used to predict average cognition in the patient group. Results: Most deep GM volumes were reduced in patients, with larger effects on average in men (−11%) than in women (−6.3%). Only the bilateral hippocampus, amygdala, and right nucleus accumbens in men, and right hippocampus and nucleus accumbens, bilateral amygdala, and putamen in women, showed no atrophy compared to controls. All cognitive domains except visuospatial memory were affected in men; none were significantly affected in women. In the MS group, average cognition was best predicted by thalamic volume, sex, and education (adjusted R2 = 0.31), while lesion volume was not a significant predictor in the model. Conclusions: Six years postdiagnosis, almost all subcortical structures were affected by MS, especially in men. Cognition was most severely affected in male patients. Thalamic volume, sex, and education best predicted average cognition. These results underline the relevance of specific subcortical structures to cognition, as well as the relevance of (sex-specific) atrophy in MS.

[1]  M. Sá,et al.  Cognitive Dysfunction in Multiple Sclerosis , 2012, Front. Neur..

[2]  R. Benedict,et al.  Risk factors for and management of cognitive dysfunction in multiple sclerosis , 2011, Nature Reviews Neurology.

[3]  Stephen M. Rao,et al.  Cognitive dysfunction in multiple sclerosis. , 1991, Neurology.

[4]  M. Belke,et al.  Men and women are different: Diffusion tensor imaging reveals sexual dimorphism in the microstructure of the thalamus, corpus callosum and cingulum , 2011, NeuroImage.

[5]  D. Chard,et al.  Predicting the development of multiple sclerosis , 2011, Neurology.

[6]  R. Rudick,et al.  Gray matter atrophy in multiple sclerosis: A longitudinal study , 2008, Annals of neurology.

[7]  S. Tiwari-Woodruff,et al.  Differential neuroprotective and antiinflammatory effects of estrogen receptor (ER)alpha and ERbeta ligand treatment. , 2007, Proceedings of the National Academy of Sciences of the United States of America.

[8]  S. Rombouts,et al.  The contribution of MRI in assessing cognitive impairment in multiple sclerosis , 2010, Neurology.

[9]  Alan C. Evans,et al.  Age- and Gender-Related Differences in the Cortical Anatomical Network , 2009, The Journal of Neuroscience.

[10]  Stephen M. Smith,et al.  A Bayesian model of shape and appearance for subcortical brain segmentation , 2011, NeuroImage.

[11]  Francis Eustache,et al.  Quantification and clinical relevance of brain atrophy in multiple sclerosis: a review , 2009, Journal of Neurology.

[12]  M. Calabrese,et al.  The predictive value of gray matter atrophy in clinically isolated syndromes , 2011, Neurology.

[13]  Robert Zivadinov,et al.  Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis , 2011, Journal of Neurology.

[14]  Stephen M. Smith,et al.  Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis , 2002, NeuroImage.

[15]  Hirofumi Ochi,et al.  [Cognitive impairment in multiple sclerosis]. , 2014, Brain and nerve = Shinkei kenkyu no shinpo.

[16]  Robert Zivadinov,et al.  Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis. , 2006, Archives of neurology.

[17]  M. Battaglini,et al.  Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes , 2010, Neurology.

[18]  J. Kurtzke Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[19]  C. Enzinger,et al.  Gender differences in MRI studies on multiple sclerosis , 2009, Journal of the Neurological Sciences.

[20]  S. Reingold,et al.  Defining the clinical course of multiple sclerosis , 1996, Neurology.

[21]  K. Cosgrove,et al.  Evolving Knowledge of Sex Differences in Brain Structure, Function, and Chemistry , 2007, Biological Psychiatry.

[22]  F. Barkhof,et al.  Functional adaptive changes within the hippocampal memory system of patients with multiple sclerosis , 2012, Human brain mapping.

[23]  S. Sorbi,et al.  Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years. , 2001, Archives of neurology.

[24]  C. J. Stam,et al.  Cognition is related to resting-state small-world network topology: an magnetoencephalographic study , 2011, Neuroscience.

[25]  D. Louis Collins,et al.  Evaluation of automated techniques for the quantification of grey matter atrophy in patients with multiple sclerosis , 2010, NeuroImage.

[26]  V. Dousset,et al.  MRI predictors of cognitive outcome in early multiple sclerosis , 2011, Neurology.

[27]  Y. Ao,et al.  Neuroprotection mediated through estrogen receptor-α in astrocytes , 2011, Proceedings of the National Academy of Sciences.

[28]  Daniel Rueckert,et al.  An evaluation of four automatic methods of segmenting the subcortical structures in the brain , 2009, NeuroImage.

[29]  J. L. Cox,et al.  Gender-related differences in MS: a study of conventional and nonconventional MRI measures , 2009, Multiple sclerosis.

[30]  David H. Miller,et al.  Imaging outcomes for neuroprotection and repair in multiple sclerosis trials , 2009, Nature Reviews Neurology.

[31]  Stephen M. Rao,et al.  Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS , 2009, Multiple sclerosis.

[32]  Rhonda R. Voskuhl,et al.  Differential neuroprotective and antiinflammatory effects of estrogen receptor (ER)α and ERβ ligand treatment , 2007, Proceedings of the National Academy of Sciences.

[33]  F. Barkhof,et al.  Clinical correlations of brain lesion distribution in multiple sclerosis , 2009, Journal of magnetic resonance imaging : JMRI.

[34]  O. Kantarci,et al.  Gray Matter Atrophy Is Related to Long-Term Disability in Multiple Sclerosis , 2009 .

[35]  S. Rivest,et al.  Estrogen Receptor Transrepresses Brain Inflammation , 2011, Cell.

[36]  M. Filippi,et al.  Functional MR Imaging Correlates of Neuropsychological Impairment in Primary-Progressive Multiple Sclerosis , 2010, American Journal of Neuroradiology.

[37]  Rohit Bakshi,et al.  Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. , 2004, Archives of neurology.

[38]  C R G Guttmann,et al.  Thalamic atrophy and cognition in multiple sclerosis , 2007, Neurology.

[39]  C. Caltagirone,et al.  Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis , 2004, Journal of Neurology.

[40]  P. Rieckmann,et al.  The natural history of secondary progressive multiple sclerosis , 2010, Journal of Neurology, Neurosurgery & Psychiatry.